1. Home
  2. ARWR vs EXG Comparison

ARWR vs EXG Comparison

Compare ARWR & EXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • EXG
  • Stock Information
  • Founded
  • ARWR 2003
  • EXG 2007
  • Country
  • ARWR United States
  • EXG United States
  • Employees
  • ARWR N/A
  • EXG N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • EXG Finance Companies
  • Sector
  • ARWR Health Care
  • EXG Finance
  • Exchange
  • ARWR Nasdaq
  • EXG Nasdaq
  • Market Cap
  • ARWR 2.5B
  • EXG 2.7B
  • IPO Year
  • ARWR 1993
  • EXG N/A
  • Fundamental
  • Price
  • ARWR $22.03
  • EXG $8.92
  • Analyst Decision
  • ARWR Buy
  • EXG
  • Analyst Count
  • ARWR 8
  • EXG 0
  • Target Price
  • ARWR $43.14
  • EXG N/A
  • AVG Volume (30 Days)
  • ARWR 2.5M
  • EXG 533.2K
  • Earning Date
  • ARWR 08-07-2025
  • EXG 01-01-0001
  • Dividend Yield
  • ARWR N/A
  • EXG 8.27%
  • EPS Growth
  • ARWR N/A
  • EXG N/A
  • EPS
  • ARWR N/A
  • EXG N/A
  • Revenue
  • ARWR $572,976,000.00
  • EXG N/A
  • Revenue This Year
  • ARWR $22,306.37
  • EXG N/A
  • Revenue Next Year
  • ARWR N/A
  • EXG N/A
  • P/E Ratio
  • ARWR N/A
  • EXG N/A
  • Revenue Growth
  • ARWR 2816.20
  • EXG N/A
  • 52 Week Low
  • ARWR $9.57
  • EXG $6.78
  • 52 Week High
  • ARWR $27.34
  • EXG $8.15
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 68.08
  • EXG 60.41
  • Support Level
  • ARWR $20.45
  • EXG $8.79
  • Resistance Level
  • ARWR $22.75
  • EXG $8.96
  • Average True Range (ATR)
  • ARWR 1.05
  • EXG 0.07
  • MACD
  • ARWR 0.26
  • EXG 0.01
  • Stochastic Oscillator
  • ARWR 86.98
  • EXG 84.48

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About EXG Eaton Vance Tax-Managed Global Diversified Equity Income Fund of Beneficial Interest

Eaton Vance Tax-Mgd Glbl Div Eq Inc is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary focus of the fund is capital appreciation. It invests in a diversified portfolio of domestic and foreign common stocks, emphasizing dividend-paying stocks. It writes call options on one or more U.S. and foreign indices for a portion of the value of its common stock portfolio to generate current cash flow from the options premium received. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, consumable fuels, and other sectors.

Share on Social Networks: